INHIBRX BIOSCIENCES, INC. Common Stock, Capital Shares Reserved for Future Issuance
INHIBRX BIOSCIENCES, INC. (INBX) had Common Stock, Capital Shares Reserved for Future Issuance of 4.92 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 4.92M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 5.02M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 5.13M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 5.11M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 4.92M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 5.02M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 5.13M shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 5.11M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 5.13M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 5.13M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 4.99M shares 10-K · filed 2026-03-19 |
| 2024-09-30 | 4.99M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 4.99M shares 10-Q · filed 2024-08-13 |
| 2023-12-31 | 13.79M shares 10-K · filed 2025-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |